BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 20960377)

  • 21. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
    Geisler CE; Renquist BJ
    J Endocrinol; 2017 Jul; 234(1):R1-R21. PubMed ID: 28428362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conjugated linoleic acid does not reduce body fat but decreases hepatic steatosis in adult Wistar rats.
    Purushotham A; Shrode GE; Wendel AA; Liu LF; Belury MA
    J Nutr Biochem; 2007 Oct; 18(10):676-84. PubMed ID: 17368879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoplasmic reticulum stress: a new actor in the development of hepatic steatosis.
    Flamment M; Kammoun HL; Hainault I; Ferré P; Foufelle F
    Curr Opin Lipidol; 2010 Jun; 21(3):239-46. PubMed ID: 20463471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver.
    You M; Crabb DW
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G1-6. PubMed ID: 15194557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the lipogenic pathway in the development of hepatic steatosis.
    Postic C; Girard J
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):643-8. PubMed ID: 19195625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic triglyceride synthesis and nonalcoholic fatty liver disease.
    Choi SS; Diehl AM
    Curr Opin Lipidol; 2008 Jun; 19(3):295-300. PubMed ID: 18460922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethanol consumption impairs regulation of fatty acid metabolism by decreasing the activity of AMP-activated protein kinase in rat liver.
    García-Villafranca J; Guillén A; Castro J
    Biochimie; 2008 Mar; 90(3):460-6. PubMed ID: 17997005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curcumin decreases oleic acid-induced lipid accumulation via AMPK phosphorylation in hepatocarcinoma cells.
    Kang OH; Kim SB; Seo YS; Joung DK; Mun SH; Choi JG; Lee YM; Kang DG; Lee HS; Kwon DY
    Eur Rev Med Pharmacol Sci; 2013 Oct; 17(19):2578-86. PubMed ID: 24142602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD).
    Musso G; Gambino R; Cassader M
    Prog Lipid Res; 2009 Jan; 48(1):1-26. PubMed ID: 18824034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin.
    Sugden MC; Bulmer K; Gibbons GF; Knight BL; Holness MJ
    Biochem J; 2002 Jun; 364(Pt 2):361-8. PubMed ID: 12023878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rutin inhibits oleic acid induced lipid accumulation via reducing lipogenesis and oxidative stress in hepatocarcinoma cells.
    Wu CH; Lin MC; Wang HC; Yang MY; Jou MJ; Wang CJ
    J Food Sci; 2011 Mar; 76(2):T65-72. PubMed ID: 21535797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance to high-fat diet-induced obesity and altered expression of adipose-specific genes in HSL-deficient mice.
    Harada K; Shen WJ; Patel S; Natu V; Wang J; Osuga J; Ishibashi S; Kraemer FB
    Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1182-95. PubMed ID: 12954598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.
    Goetzman ES; Tian L; Wood PA
    Mol Genet Metab; 2005 Jan; 84(1):39-47. PubMed ID: 15639194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
    J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease.
    Videla LA; Rodrigo R; Araya J; Poniachik J
    Free Radic Biol Med; 2004 Nov; 37(9):1499-507. PubMed ID: 15454290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoplasmic reticulum stress involved in the course of lipogenesis in fatty acids-induced hepatic steatosis.
    Liu J; Jin X; Yu CH; Chen SH; Li WP; Li YM
    J Gastroenterol Hepatol; 2010 Mar; 25(3):613-8. PubMed ID: 19929925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats.
    Aragno M; Tomasinelli CE; Vercellinatto I; Catalano MG; Collino M; Fantozzi R; Danni O; Boccuzzi G
    Free Radic Biol Med; 2009 Oct; 47(7):1067-74. PubMed ID: 19616615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of genes involved in lipid metabolism by dietary oxidized fat.
    Ringseis R; Eder K
    Mol Nutr Food Res; 2011 Jan; 55(1):109-21. PubMed ID: 21207516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis.
    Doege H; Baillie RA; Ortegon AM; Tsang B; Wu Q; Punreddy S; Hirsch D; Watson N; Gimeno RE; Stahl A
    Gastroenterology; 2006 Apr; 130(4):1245-58. PubMed ID: 16618416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prebiotic approach alleviates hepatic steatosis: implication of fatty acid oxidative and cholesterol synthesis pathways.
    Pachikian BD; Essaghir A; Demoulin JB; Catry E; Neyrinck AM; Dewulf EM; Sohet FM; Portois L; Clerbaux LA; Carpentier YA; Possemiers S; Bommer GT; Cani PD; Delzenne NM
    Mol Nutr Food Res; 2013 Feb; 57(2):347-59. PubMed ID: 23203768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.